A conversation on PrEP and its impact on new HIV cases

Learn from infectious disease experts about the impact of PrEP on reducing the amount of new HIV cases, PrEP implementation in office, guidance from the CDC on testing required to start and manage people on PrEP, and cost savings associated with United States Preventive Services Task Force (USPSTF) guidelines.

Speakers: Sarah Henn, MD, MPH and Charles Walworth, MD